SOU MIYAKE
Head of Venture Investments CSB
Dr. Sou Miyake leads venture investments at CSB, focusing on microbiome innovation and health security. He holds a PhD in molecular microbiology and has a diverse background spanning scientific research, management consulting at L.E.K., and strategic roles in e-commerce and life sciences. Sou previously worked at Temasek Life Sciences Laboratory and Shopee, bringing a unique blend of technical expertise and business strategy to his investment approach. At CSB, he supports startups developing cutting-edge solutions in microbiome science and biotechnology.
Seminars
Wednesday 28th January 2026
Panel Discussion: Rebuilding Investor Confidence in Microbiome Therapeutics to Unlock Capital
4:00 pm
- Highlight data-driven milestones that attract funding to unlock capital
- Structure deals to balance risk and reward for early-stage ventures to improve term-sheet appeal
- Position platforms for scalability and exit potential to attract strategic investment
Key Session
